Pfizer taps Deutsch for Zyrtec

Published on .

Pfizer, New York, has awarded Deutsch, New York the estimated $75 million account for its anti-allergy drug Zyrtec. Deutsch bested McCann-Erickson Worldwide, Merkley Newman Harty and Ogilvy & Mather Worldwide, all New York, to win the account. The previous agency was HMC, New York. Advice & Advisors, New York, consulted on the review.

Copyright August 1999, Crain Communications Inc.

In this article:
Most Popular